Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Creatine deficiency syndromes].

D Cheillan1, S Cognat, N Vandenberghe

  • 1Service de Biochimie Pédiatrique, Hôpital Debrousse, 29, rue Soeur-Bouvier, 69322 Lyon, France. david.cheillan@chu-lyon.fr

Revue Neurologique
|April 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gut commensal Bacteroides faecichinchillae, a potential novel candidate of next-generation probiotics targeting type 2 diabetes.

Beneficial microbes·2026
Same author

STAG2 microduplication in a patient with eyelid myoclonia and absences and a review of EMA-related reported genes.

European journal of medical genetics·2022
Same author

Neonatal screening for congenital hypothyroidism: Time to lower the TSH threshold in France.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
Same author

Mode Coarsening or Fracture: Energy Transfer Mechanisms in Dynamic Buckling of Rods.

Physical review letters·2021
Same author

Unusual early-onset and severe adrenomyeloneuropathy in women.

European journal of neurology·2020
Same author

Large triglyceride-rich lipoproteins from fasting patients with type 2 diabetes activate platelets.

Diabetes & metabolism·2019
Same journal

Macrophage inclusions in patients undergoing antisense oligonucleotide therapy for ALS or SMA: A retrospective and transversal study.

Revue neurologique·2026
Same journal

Geographic disparities in MRI features of ischemic stroke and small vessel disease: A comparative study between French Guiana and mainland France. Findings from the BECATOUR multicenter registry.

Revue neurologique·2026
Same journal

Continuous subcutaneous perfusion of apomorphine in Parkinson's disease: Towards monotherapy?

Revue neurologique·2026
Same journal

Neuro-Whipple presenting as autoimmune encephalitis.

Revue neurologique·2026
Same journal

Multimodal assessment of minimally conscious state and cognitive motor dissociation in neurocritical care: A critical review.

Revue neurologique·2026
Same journal

Development of a new episodic memory assessment tool (NEM): Preliminary data and clinical perspectives.

Revue neurologique·2026
See all related articles

Creatine deficiency syndromes, including AGAT, GAMT, and CRTR, impact brain creatine levels, causing developmental delays. Early diagnosis and treatment with creatine supplementation are crucial for AGAT and GAMT deficiencies.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Context:

  • Inborn errors of metabolism affecting creatine metabolism.
  • Characterized by depletion of brain creatine/phosphocreatine.
  • Includes arginine: glycine amidinotransferase (AGAT), guanidinoacetate methyltransferase (GAMT), and creatine transporter defect (CRTR).

Purpose:

  • To describe creatine deficiency syndromes.
  • To highlight clinical manifestations and diagnostic methods.
  • To differentiate treatable from untreatable forms.

Summary:

  • Creatine deficiency syndromes (AGAT, GAMT, CRTR) result in depleted brain creatine, leading to mental retardation, speech delay, and seizures.
  • Diagnosis involves measuring guanidinoacetate and creatine in biological fluids and using proton magnetic resonance spectroscopy.

Related Experiment Videos

  • GAMT and AGAT deficiencies are treatable with creatine supplementation, unlike CRTR.

    • Impact:

    • Emphasizes the need for increased awareness and understanding of these rare metabolic disorders.
    • Aims to improve diagnostic accuracy and patient management strategies.
    • Highlights the potential for effective treatment in specific creatine deficiency syndromes.